TY - JOUR T1 - Functional Consequences of Reduced Retinoic Acid Receptor γ Expression in a Human Squamous Cell Carcinoma Line JF - Molecular Pharmacology JO - Mol Pharmacol SP - 377 LP - 382 VL - 51 IS - 3 AU - Ricardo I. Monzon AU - Catherine Fillmore AU - Laurie G. Hudson Y1 - 1997/03/01 UR - http://molpharm.aspetjournals.org/content/51/3/377.abstract N2 - Nuclear receptors for retinoic acid are important modulators of epidermal cell proliferation and terminal differentiation. Aberrant expression of retinoic acid receptors (RARs) and retinoid X receptors in the epidermis has been associated with altered differentiation capacity and tumor progression. In this study, we describe a human squamous cell carcinoma line, SCC 12F, which displays reduced RARγ expression and diminished responsiveness to retinoic acid. When compared with normal keratinocytes or other squamous cell carcinoma lines that display normal levels of RARγ, several measures of cellular response to retinoic acid are altered in SCC 12F cells, including inhibition of cornified envelope formation, reduction of involucrin mRNA expression, and transcriptional regulation of the involucrin gene. Normal patterns of ligand-dependent transcriptional response were restored upon co-transfection of an expression vector containing either RARα or RARγ. Our findings demonstrate that reduced expression of RAR may have direct functional consequences with regard to keratinocyte differentiation and that the defect may be alleviated by reintroduction of functional receptor. The American Society for Pharmacology and Experimental Therapeutics ER -